Regeneron Pharmaceuticals Inc said U.S. regulators have denied approval for it to expand use of its Arcalyst drug to prevent gout flares, asking that the company provide more clinical data
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment